3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Myelodysplastic Syndromes
8
Advanced Solid Tumors
8
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Ovarian Neoplasms
4
Neoplasms
4
Multiple Myeloma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumour
4
Advanced Solid Tumor
4
Small Cell Lung Carcinoma
3
Recurrence
3
Leukemia, Monocytic, Acute
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Malignant Solid Tumor
2
Advanced Lung Cancer
2
Interventions
pembrolizumab
22
Nivolumab
14
enfortumab vedotin
13
Gemcitabine
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cisplatin
8
Carboplatin
8
sacituzumab govitecan
6
avelumab
6
Docetaxel
6
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Injections
×
90 days
×
Clear all
No trials found.